Method for treating bone fracture with anti-sclerostin antibodies

Details for Australian Patent Application No. 2008338464 (hide)

Owner Amgen Inc.

Inventors Ke, Hua Zhu

Agent Davies Collison Cave

Pub. Number AU-A-2008338464

PCT Pub. Number WO2009/079471

Priority 61/013,917 14.12.07 US

Filing date 15 December 2008

Wipo publication date 25 June 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 19/00 (2006.01) Drugs for skeletal disorders

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

10 June 2010 PCT application entered the National Phase

  PCT publication WO2009/079471 Priority application(s): WO2009/079471

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008338479-Enhanced photostability of avobenzone in the presence of zinc oxide using phosphate-based emulsifiers

2008338457-Thermal curable polyester powder coating composition